The decline of salivary adenocarcinoma not otherwise specified as a tumor entity reclassification using contemporary immunohistochemical profiling and diagnostic criteria

Lisa M. Rooper, Mena Mansour, Raluca Yonescu, Bahram R. Oliai, Justin A. Bishop, William H. Westra

Research output: Contribution to journalArticlepeer-review

Abstract

The classification of salivary gland carcinomas has become increasingly specific over the last decade with the definition of new tumor types, documentation of novel molecular and immunohistochemical findings, and development of more refined diagnostic criteria. In this setting, it is unclear how many salivary tumors still cannot be easily categorized-and whether such tumors represent undifferentiated malignancies or include additional definable entities. Relying largely on current classification schemes and contemporary immunohistochemical panels, we reassessed salivary tumors previously diagnosed as adenocarcinoma, not otherwise specified (ACA NOS) from 2 large academic medical centers. Fifty-seven ACA NOS (72%) could be reclassified as more specific entities including 31 salivary duct carcinomas (39%), 7 polymorphous adenocarcinomas (9%), 5 epithelial-myoepithelial carcinomas (6%), 4 myoepithelial carcinomas (5%), 4 secretory carcinomas (5%), 1 acinic cell carcinoma (1%), 1 basal cell adenocarcinoma (1%), 1 intraductal carcinoma (1%), and 1 clear cell carcinoma (1%) as well as 2 metastatic squamous cell carcinomas (3%). Of reclassified cases, 21 (37%) represented variant histologies within these categories. ACA NOS comprised 11% of salivary malignancies before reclassification, but only 4% after reclassification. The remaining 22 ACA NOS demonstrated heterogeneous features, with an association between histologic grade and clinical outcome. In effect, ACA NOS is becoming a bygone entity as modern classification schemes and ancillary techniques now permit more specific typing of a majority of these tumors, potentially facilitating more specific prognostication and treatment. Additional distinctive entities such as mucinous adenocarcinoma may still be definable within the ACA NOS category.

Original languageEnglish (US)
Pages (from-to)753-764
Number of pages12
JournalAmerican Journal of Surgical Pathology
Volume45
Issue number6
DOIs
StatePublished - Jun 2021

Keywords

  • Adenocarcinoma not otherwise specified
  • Immunohistochemistry
  • Polymorphous adenocarcinoma
  • Salivary duct carcinoma
  • Salivary gland neoplasms
  • Secretory carcinoma

ASJC Scopus subject areas

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'The decline of salivary adenocarcinoma not otherwise specified as a tumor entity reclassification using contemporary immunohistochemical profiling and diagnostic criteria'. Together they form a unique fingerprint.

Cite this